BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31993745)

  • 1. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.
    Williams GP; Marmion DJ; Schonhoff AM; Jurkuvenaite A; Won WJ; Standaert DG; Kordower JH; Harms AS
    Acta Neuropathol; 2020 May; 139(5):855-874. PubMed ID: 31993745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
    Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
    Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy.
    Corbin-Stein NJ; Childers GM; Webster JM; Zane A; Yang YT; Mudium N; Gupta R; Manfredsson FP; Kordower JH; Harms AS
    Acta Neuropathol Commun; 2024 Jan; 12(1):11. PubMed ID: 38238869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
    Mandler M; Valera E; Rockenstein E; Mante M; Weninger H; Patrick C; Adame A; Schmidhuber S; Santic R; Schneeberger A; Schmidt W; Mattner F; Masliah E
    Mol Neurodegener; 2015 Mar; 10():10. PubMed ID: 25886309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
    Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
    J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
    Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
    Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
    Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
    Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
    Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
    PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue resident memory CD8+ T cells are present but not critical for demyelination and neurodegeneration in a mouse model of multiple system atrophy.
    Corbin-Stein NJ; Childers GM; Webster JM; Zane A; Yang YT; Ali MA; Sandoval IM; Manfredsson FP; Kordower JH; Tyrrell DJ; Harms AS
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
    Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
    Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.
    May VE; Ettle B; Poehler AM; Nuber S; Ubhi K; Rockenstein E; Winner B; Wegner M; Masliah E; Winkler J
    Neurobiol Aging; 2014 Oct; 35(10):2357-68. PubMed ID: 24698767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration.
    Harms AS; Delic V; Thome AD; Bryant N; Liu Z; Chandra S; Jurkuvenaite A; West AB
    Acta Neuropathol Commun; 2017 Nov; 5(1):85. PubMed ID: 29162163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.